8
Vivani MC y cols. Comparación del cáncer de la orofaringe HPV relacionado y no relacionado. Rev Argent Cir. 2025;117(2):e-1827
will become a significant priority in the future is as a risk factor for malignant transformaꢀon and the
1
5
compelling . This study showed that the HPV+ OPSSC development of HPV+ OPSCC, and it remains a tumor
has significantly increased and that the detecꢀon of HPV with a relaꢀvely favorable prognosis. This is evidenced
virus in this type of tumors is crucial, as the prognosis by the lower clinical stage of the TNM classificaꢀon
and treatment differ from those of HPV- tumors. system compared to that of HPV-OPSCC in the new
Although vaccinaꢀon has the potenꢀal to reverse the staging system of the 2017 American Joint Commiꢁee
th
18
incidence trend, HPV vaccinaꢀon rates remain low on Cancer, 8 ediꢀon .
worldwide, and the long latency of the virus poses
In conclusion, a higher number of paꢀents
challenges in assessing the true prevenꢀve impact of were idenꢀfied with HPV+ OPSCC in comparison to HPV-
1
6,17
.
HPV vaccinaꢀon
tumors, with a greater tendency to manifest at earlier
As with all studies, this one has both stages and to be more oꢃen treated with surgery.
weaknesses and strengths. First, HPV was detected Although these differences were not staꢀsꢀcally
indirectly by measuring p16 by immunohistochemistry. significant due to the small sample size, they are similar
Second, survival analysis was not possible due to to those found in larger internaꢀonal studies.
sample size and loss of data biased by deaths. However,
Further research is necessary to determine
the strength of the study was the ability to detect HPV the most effecꢀve therapeuꢀc approaches according
retrospecꢀvely, the rigorous and systemaꢀc follow-up to tumor eꢀology, the necessity of eꢀologic diagnosis
of paꢀents from the ꢀme of diagnosis, and the fact that prior to treatment, and the impact of mandatory HPV
it was the first study on the subject in Argenꢀna and vaccinaꢀon on disease prevalence.
was carried out enꢀrely in a specialized public hospital,
Acknowledgments: We would like to express our graꢁtude
by the same team and in a mulꢀdisciplinary manner.
to Dr. Gabriela Marcerveli, oncologist, for her selfless
A persistent oral HPV infecꢀon is regarded
collaboraꢁon.
Referencias bibliográficas /References
1
.
Seijas-Tamayo R, Fernández-Mateos J, Adansa Klain JC, Mesía R,
Pastor Borgoñón M, Pérez-Ruiz E, et al. Epidemiological characte-
risꢀcs of a Spanish cohort of paꢀents diagnosed with squamous
cell carcinoma of head and neck: distribuꢀon of risk factors by tu-
mor locaꢀon. Clin Transl Oncol [Internet]. 2016 ;18(11):1114-22.
Available from: hꢁp://dx.doi.org/10.1007/s12094-016-1493-1
Dalianis T. Human papillomavirus (HPV) and oropharyngeal squa-
mous cell carcinoma. Presse Med [Internet]. 2014;43(12):e429-34.
Available from: ꢁp://dx.doi.org/10.1016/j.lpm.2014.08.010
Lehꢀnen T, Elfström KM, Mäkiꢀe A, Nygård M, Vänskä S, Pawlita
M, et al. Eliminaꢀon of HPV–associated oropharyngeal cancers in
Nordic countries. Prev Med [Internet]. 2021;144:106445. Availa-
ble from: hꢁp://dx.doi.org/10.1016/j.ypmed.2021.106445
Sheedy T, Heaton C. HPV-associated oropharyngeal cancer. JA-
APA [Internet]. 2019;32(9):26-31. Available from hꢁp://dx.doi.
org/10.1097/01.jaa.0000578756.52642.cb
Viruses [Internet]. 2021,9;13(7):1326. Available from: tp://dx.doi.
org/10.3390/v13071326
10. R Core Team. R: A Language and Environment for Staꢀsꢀcal
Compuꢀng [Internet]. Vienna, Austria: R Foundaꢀon for Staꢀs-
ꢀcal Compuꢀng; 2020. Available from: hꢁps://www.R-project.
org/
2
3
.
.
11. Tanaka TI, Alawi F. Human Papillomavirus and oropharyngeal can-
cer. Dent Clin North Am [Internet]. 2018 ;62(1):111–20. Available
from: hꢁp://dx.doi.org/10.1016/j.cden.2017.08.008
12. Ference R, Liao D, Gao Q, Mehta V. Impact of smoking on
survival outcomes in HPV-related oropharyngeal carcino-
ma:
A meta-analysis. Otolaryngol Head Neck Surg [Inter-
net]. 2020 ;163(6):1114-22. Available from: hꢁp://dx.doi.
org/10.1177/0194599820931803
4
5
.
.
13. Taberna M, Mena M, Pavón MA, Alemany L, Gillison ML, Mesía R.
Human papillomavirus-related oropharyngeal cancer. Ann Oncol
[Internet]. 2017 ;28(10):2386-98. Available from: hꢁp://dx.doi.
org/10.1093/annonc/mdx304
Marur S, D’Souza G, Westra WH, Forasꢀere AA. HPV-associated
head and neck cancer: a virus-related cancer epidemic. Lancet
Oncol [Internet]. 2010;11(8):781-9. Available from: hꢁp://dx.doi.
org/10.1016/S1470-2045(10)70017-6
14. Yoshida EJ, Luu M, Mallen-St Clair J, Mita AC, Scher KS, Lu DJ, et
al. Stage I HPV-posiꢀve oropharyngeal cancer: Should all paꢀents
receive similar treatments? Cancer [Internet]. 2020 1;126(1):58-
66. Available from: hꢁp://dx.doi.org/10.1002/cncr.32501
15. De Virgilio A, Costanꢀno A, Mercante G, Pellini R, Ferreli F, Mal-
vezzi L, et al. Transoral roboꢀc surgery and intensity-modulated
radiotherapy in the treatment of the oropharyngeal carcinoma: a
systemaꢀc review and meta-analysis. Eur Arch Otorhinolaryngol
[Internet]. 2021 ;278(5):1321-35. Available from: hꢁp://dx.doi.
org/10.1007/s00405-020-06224-z
6
7
.
.
Lechner M, Liu J, Masterson L, Fenton TR. HPV-associated
oropharyngeal cancer: epidemiology, molecular biology and cli-
nical management. Nat Rev Clin Oncol [Internet]. 2022;19(5):306-
2
0
7. Available from: hꢁp://dx.doi.org/10.1038/s41571-022-
0603-7
Sood A, Wykes J, Roshan D, Wang LY, McGuinness J, Fowler A, et
al. A criꢀcal analysis of the prognosꢀc performance of the 8th edi-
ꢀ
on American Joint Commiꢁee on Cancer staging for metastaꢀc
cutaneous squamous cell carcinoma of the head and neck. Head
Neck [Internet]. 2019;41(6):1591-6. Available from: hꢁp://dx.doi.
org/10.1002/hed.25599
16. De Felice F, Polimeni A, Tombolini V. Human papillomavirus (HPV)
vaccine and HPV-related head and neck cancer: What’s next? Oral
Oncol [Internet]. 2019;93:125-6. Available from: ꢁp://dx.doi.
org/10.1016/j.oraloncology.2019.04.001
8
9
.
.
Haeggblom L, Ramqvist T, Tommasino M, Dalianis T, Näsman A.
Time to change perspecꢀves on HPV in oropharyngeal cancer. A
systemaꢀc review of HPV prevalence per oropharyngeal sub-site
the last 3 years. Papillomavirus Res [Internet]. 2017;4:1-11. Avai-
lable from: hꢁp://dx.doi.org/10.1016/j.pvr.2017.05.002
Carlander AF, Jakobsen KK, Bendtsen SK, Garset-Zamani M, Lyng-
gaard CD, Jensen JS, et al. A contemporary systemaꢀc review on
reparꢀꢀon of HPV-posiꢀvity in oropharyngeal cancer worldwide.
17. Du J, Ährlund-Richter A, Näsman A, Dalianis T. Human papilloma
virus (HPV) prevalence upon HPV vaccinaꢀon in Swedish youth: a
review based on our findings 2008-2018, and perspecꢀves on can-
cer prevenꢀon. Arch Gynecol Obstet [Internet]. 2021;303(2):329-
35. Available from: hꢁp://dx.doi.org/10.1007/.
18. American Joint Commiꢁee on Cancer Staging Manual. 8th Ediꢀon.
Chicago: Springer; 2017.